Arkolith/Insider Trading/AXSM/Form 4

Pizzie Nick

Chief Financial OfficerAxsome Therapeutics, Inc. (AXSM) · full profile →Form 4 · filed Jan 23, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.3M
Net Open-Market Flow
-$2.3M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 22, 2026Option exercise(M)12K$3.50$42K55K
Jan 22, 2026Sell(S)12K$187.92$2.3M43K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 22, 2026Option exercise(M)12K—$0105K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-021378) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML